CANCER BREAKTHROUGH
RNA breakthrough targets a notoriously ‘undruggable’ cancer gene
Inspired by nature, the new technique allows researchers to neutralize and inhibit the cancer gene MYC
Proteins play a crucial role in the growth, division, and spread of cancer cells, making them attractive targets for cancer research and therapy. However, the complexity of cancer and the intricate molecular mechanisms involved pose significant challenges in developing effective treatments. To add to that, many cancer-driving proteins are notoriously difficult to target and inhibit due to several reasons
Despite these obstacles, researchers are actively working on innovative strategies and technologies to tackle these elusive cancer-driving proteins. Advances in fields such as structural biology, genomics, proteomics, and targeted drug delivery systems are providing valuable insights and tools to better understand these proteins and develop more precise and effective therapeutic interventions.
MYC cancer gene stands as one of the most crucial and formidable drug targets, with its activation implicated in 70% or more of all human cancers. Its influence extends to orchestrating the expression or suppression of numerous other genes. MYC impacts various cellular…
